Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy BioCardia stock | $2.71

Learn how to easily invest in BioCardia stock.

BioCardia Inc is a biotechnology business based in the US. BioCardia shares (BCDA) are listed on the NASDAQ and all prices are listed in US Dollars. BioCardia employs 24 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in BioCardia

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BCDA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

BioCardia stock price (NASDAQ: BCDA)

Use our graph to track the performance of BCDA stocks over time.

BioCardia shares at a glance

Information last updated 2021-10-23.
Latest market close$2.71
52-week range$1.91 - $6.50
50-day moving average $3.04
200-day moving average $3.56
Wall St. target price$11.17
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.90

Buy BioCardia shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy BioCardia stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BioCardia price performance over time

Historical closes compared with the close of $2.71 from 2021-10-26

1 week (2021-10-21) -7.35%
1 month (2021-09-28) -19.35%
3 months (2021-07-28) -21.45%
6 months (2021-04-28) -23.88%
1 year (2020-10-27) 32.20%
2 years (2019-10-25) -35.32%
3 years (2018-10-26) 10.61%
5 years (2016-10-27) 1,835.71%

BioCardia financials

Revenue TTM $195,000
Gross profit TTM $-9,668,000
Return on assets TTM -51.76%
Return on equity TTM -115.77%
Profit margin 0%
Book value $0.93
Market capitalisation $47.6 million

TTM: trailing 12 months

Shorting BioCardia shares

There are currently 259,983 BioCardia shares held short by investors – that's known as BioCardia's "short interest". This figure is 33.2% up from 195,222 last month.

There are a few different ways that this level of interest in shorting BioCardia shares can be evaluated.

BioCardia's "short interest ratio" (SIR)

BioCardia's "short interest ratio" (SIR) is the quantity of BioCardia shares currently shorted divided by the average quantity of BioCardia shares traded daily (recently around 317052.43902439). BioCardia's SIR currently stands at 0.82. In other words for every 100,000 BioCardia shares traded daily on the market, roughly 820 shares are currently held short.

However BioCardia's short interest can also be evaluated against the total number of BioCardia shares, or, against the total number of tradable BioCardia shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BioCardia's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 BioCardia shares in existence, roughly 20 shares are currently held short) or 0.0182% of the tradable shares (for every 100,000 tradable BioCardia shares, roughly 18 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BioCardia.

Find out more about how you can short BioCardia stock.

BioCardia share dividends

We're not expecting BioCardia to pay a dividend over the next 12 months.

Have BioCardia's shares ever split?

BioCardia's shares were split on a 1:9 basis on 5 June 2019. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BioCardia shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for BioCardia shares which in turn could have impacted BioCardia's share price.

BioCardia share price volatility

Over the last 12 months, BioCardia's shares have ranged in value from as little as $1.91 up to $6.5. A popular way to gauge a stock's volatility is its "beta".

BCDA.US volatility(beta: 1.82)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioCardia's is 1.8199. This would suggest that BioCardia's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

BioCardia overview

BioCardia, Inc. , a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and ALLOGENEIC cell therapy for cardiac and pulmonary disease. The company is also developing ALLOGENEIC Cell Therapy System, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system, a percutaneous catheter delivery system for cardiovascular regenerative medicine; and Morph deflectable guides and sheaths. The company is based in San Carlos, California. .

Frequently asked questions

What percentage of BioCardia is owned by insiders or institutions?
Currently 31.148% of BioCardia shares are held by insiders and 22.216% by institutions.
How many people work for BioCardia?
Latest data suggests 24 work at BioCardia.
When does the fiscal year end for BioCardia?
BioCardia's fiscal year ends in December.
Where is BioCardia based?
BioCardia's address is: 125 Shoreway Road, San Carlos, CA, United States, 94070
What is BioCardia's ISIN number?
BioCardia's international securities identification number is: US09060U5074
What is BioCardia's CUSIP number?
BioCardia's Committee on Uniform Securities Identification Procedures number is: 09060U101

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site